SCHEMBL1111103

SCHEMBL1111103

CC(C)(C)OC(=O)NC(C)(C)c1ccccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.47
IMPDH2 P12268 2/20 0.44
CNR1 P21554 2/20 0.43
CNR2 P34972 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HDAC6 Q9UBN7 1/20 0.41
RAB9A P51151 3/20 0.41
MEN1 O00255 2/20 0.40
NPC1 O15118 2/20 0.40
KMT2A Q03164 2/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
METAP1 P53582 1/20 0.39
TSHR P16473 1/20 0.39
AAK1 Q2M2I8 1/20 0.38
ANO1 Q5XXA6 1/20 0.38
MAPK1 P28482 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ATR Q13535 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2085297 0.84 RAB9A (0.41) ADORA2ASMN1; SMN2L3MBTL1RAB9AMEN1
SCHEMBL20263079 0.84 RAB9A (0.41) ADORA2ASMN1; SMN2L3MBTL1RAB9AMEN1
SCHEMBL28031146 0.82 TSHR (0.39) ADORA2ACNR1CNR2SMN1; SMN2L3MBTL1
SCHEMBL23666718 0.80 IMPDH2 (0.48) ADORA2AIMPDH2CNR1CNR2SMN1; SMN2
SCHEMBL33526939 0.80 NAMPT (0.40) RAB9AMEN1NPC1KMT2AGAA
SCHEMBL24707465 0.78 AAK1 (0.39) ADORA2ARAB9AAAK1KDM4EATR
SCHEMBL7269535 0.76 AAK1 (0.41) TSHRAAK1
SCHEMBL7275375 0.76 AAK1 (0.41) TSHRAAK1
SCHEMBL26790240 0.76 IMPDH2 (0.45) ADORA2AIMPDH2CNR1CNR2SMN1; SMN2
SCHEMBL1111315 0.76 RAB9A (0.39) ADORA2ASMN1; SMN2RAB9AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426448-B2 1,5-diphenyl-pyrrolidin-2-one compounds as CB-1 ligands ELI LILLY AND COMPANY (US) 2013-04-23 US disclosed
US-8426448-B2 1,5-diphenyl-pyrrolidin-2-one compounds as CB-1 ligands ELI LILLY AND COMPANY (US) 2013-04-23 US disclosed
US-8426448-B2 1,5-diphenyl-pyrrolidin-2-one compounds as CB-1 ligands ELI LILLY AND COMPANY (US) 2013-04-23 US disclosed
US-20110028520-A1 1,5-DIPHENYL-PYRROLIDIN-2-ONE COMPOUNDS AS CB-1 LIGANDS ELI LILLY AND COMPANY (US) 2011-02-03 US disclosed
US-20110028520-A1 1,5-DIPHENYL-PYRROLIDIN-2-ONE COMPOUNDS AS CB-1 LIGANDS ELI LILLY AND COMPANY (US) 2011-02-03 US disclosed
US-20110028520-A1 1,5-DIPHENYL-PYRROLIDIN-2-ONE COMPOUNDS AS CB-1 LIGANDS ELI LILLY AND COMPANY (US) 2011-02-03 US disclosed
EP-2278968-A2 1,5-DIPHENYL-PYRROLIDIN-2-ONE COMPOUNDS AS CB-1 LIGANDS ELI LILLY AND COMPANY (US) 2011-02-02 EP disclosed
WO-2009131814-A2 1,5-DIPHENYL-PYRROLIDIN-2-ONE COMPOUNDS AS CB-1 LIGANDS ELI LILLY AND COMPANY (US) 2009-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028520-A1 1,5-DIPHENYL-PYRROLIDIN-2-ONE COMPOUNDS AS CB-1 LIGANDS CNR1, CNR2, GPR119 ADORA2A 445/4885IMPDH2 4158/4885CNR1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.